2 terminated, 1 active not recruiting, 1 enrolling by invitation, 1 not yet recruiting. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 2, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Adicet Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2 Trial of ADI-212 in mCRPC ADI-212, Fludarabine, Cyclophosphamide - Prostate Cancer Metastatic | Phase 1 / Phase 2 | Not yet recruiting | Adicet Therapeutics | 12 | 2026-09-01 | 2026-09-10 |
| A Phase 1 Study of ADI-001 in Rheumatoid Arthritis ADI-001, Fludarabine, Cyclophosphamide - Rheumatoid Arthritis (RA) | Phase 1 | Recruiting | Adicet Therapeutics | 25 | 2025-10-10 | 2025-12-08 |
| A Phase 1 Trial of ADI-270 in ccRCC ADI-270, Fludarabine, Cyclophosphamide - Clear Cell Renal Cell Carcinoma | Phase 1 | Terminated | Adicet Therapeutics | 10 | 2024-12-12 | 2026-10-27 |
| A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease ADI-001, Fludarabine, Cyclophosphamide - Lupus Nephritis, Autoimmune Diseases | Phase 1 | Enrolling by invitation | Adicet Therapeutics | 180 | 2024-11-10 | 2026-03-19 |
| Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells ADI-001 - Lymphoma, Follicular, Lymphoma, Mantle-Cell | Active not recruiting | Adicet Therapeutics | 50 | 2022-02-14 | 2026-04-09 | |
| A Phase 1 Study of ADI-001 in B Cell Malignancies ADI-001, Fludarabine, Cyclophosphamide - Lymphoma, Follicular, Lymphoma, Mantle-Cell | Phase 1 | Terminated | Adicet Therapeutics | 34 | 2021-03-04 | 2025-06-18 |
Lymphoma, B-Cell (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, Non-Hodgkin (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Carcinoma, Renal Cell (1) · Lupus Erythematosus, Systemic (1) · Lupus Nephritis (1) · Myositis (1) · Scleroderma, Systemic (1) · Stiff-Person Syndrome (1)
Cyclophosphamide (5) · fludarabine (5)
United States (5) · China (1)